Invizyne

Invizyne/eXoZymes is a pioneering biotech/platform company specializing in cell-free enzyme-based biomanufacturing systems. Their technology enables the efficient conversion of renewable resources into high-value products such as active pharmaceutical ingredients (APIs), nutraceuticals, biofuels (e.g., sustainable aviation fuel), and specialty chemicals (e.g., flavors/fragrances). The proprietary platform leverages highly engineered enzymes ("exozymes") operating outside living cells, validated in peer-reviewed journals, and supported by government funding for projects like sustainable aviation fuel. The company went public on NASDAQ (IZTC, transitioning to EXOZ) in November 2024. Initial commercialization focuses on non-pharmaceutical applications, with plans to expand into drug manufacturing.